Pricing Log in Create free account

Faeth Therapeutics, Inc. (FTH) vs Neurogene Inc. (NGNE)

Faeth Therapeutics, Inc. and Neurogene Inc. are both Biotechnology companies. Faeth Therapeutics, Inc. and Neurogene Inc. are of similar size ($514.8M and $513.3M). Across the 8 metrics below, Faeth Therapeutics, Inc. leads on 4 and Neurogene Inc. on 4.

Valuation

Metric FTH NGNE Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 3.51 2.63 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (635.04%) (19.89%) (32.88%)
Free cash flow yield (7.66%) (15.38%) (23.13%)

Profitability

Metric FTH NGNE Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (229.61%) (45.32%) (51.96%)
Return on assets (204.67%) (41.02%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric FTH NGNE Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 30.33% 0.93% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FTH NGNE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 16.12 10.64 4.97
Net debt to EBITDA 0.96 2.57 1.01

Dividend

Metric FTH NGNE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric FTH NGNE Biotechnology median
Market cap 514.81m 513.29m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack